LMGAM
HAE icon

Liberty Mutual Group Asset Management’s Haemonetics HAE Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,396
Closed -$1.19M – 344
2018
Q3 		$1.19M Hold
10,396
– – 0.02% 309
2018
Q2 		$932K Buy
+10,396
New +$878K 0.02% 406

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Liberty Mutual Group Asset Management's HAE Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Haemonetics (HAE) in Q4 2018, closing a stake of 10,396 shares — an estimated $1.19M sold.

Liberty Mutual Group Asset Management first reported a position in HAE in Q2 2018 and held it in 2 quarters. The position peaked at $1.19M in Q3 2018. 279 funds tracked by Wall St. Rank hold HAE as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Haemonetics position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 10,396 Haemonetics shares in Q4 2018, an estimated $1.19M.
  • Liberty Mutual Group Asset Management first reported a position in Haemonetics in Q2 2018 and held it in 2 quarters.
  • Liberty Mutual Group Asset Management's Haemonetics position peaked at $1.19M in Q3 2018.
  • 279 funds tracked by Wall St. Rank held Haemonetics as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.